Corrigendum to “A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)” [Vaccine 41 (2023) 3387–3398]
Titel:
Corrigendum to “A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)” [Vaccine 41 (2023) 3387–3398]
Auteur:
Martinon-Torres, Federico Wysocki, Jacek Szenborn, Leszek Carmona-Martinez, Alfonso Poder, Airi Dagan, Ron Richmond, Peter Gilbert, Christopher Trudel, Marie-Chantale Flores, Sheryl Lupinacci, Robert McFetridge, Richard Wiedmann, Richard T. Chen, Qiuxu Gerrits, Han Banniettis, Natalie Musey, Luwy Bickham, Kara Kaminski, Janusz